Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 68 (GPR68), also known as Ovarian cancer G-protein coupled receptor 1 (OGR1) or Sphingosylphosphorylcholine receptor, is a proton-sensing receptor that responds to changes in extracellular pH. It is involved in various biological activities, including inflammation, cardiovascular physiology, and tumor microenvironment modulation. GPR68 is expressed widely across tissues and is considered a potential drug target for inflammatory diseases and cancers characterized by acidic microenvironments.
Acts as a proton-sensing receptor, responding to changes in extracellular pH and activating downstream signaling pathways, including cAMP/PKA/CREB signaling. May also be regulated by certain lipid molecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 68 (GPR68).